Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics

Alzheimer's disease (AD) is characterized by progressive cognitive decline usually beginning with impairment in the ability to form recent memories. Nonavailability of definitive therapeutic strategy urges developing pharmacological targets based on cell signaling pathways. A great revival of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xuan, Zhang, Lu, Lian, Ya-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668300/
https://www.ncbi.nlm.nih.gov/pubmed/26665008
http://dx.doi.org/10.1155/2015/760758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668300/
https://www.ncbi.nlm.nih.gov/pubmed/26665008
http://dx.doi.org/10.1155/2015/760758

Ejemplares similares